| COVID-19 |
1 |
1 |
| Antiviral Agents |
0 |
0.78 |
| COVID-19 Vaccine |
0 |
0.58 |
| Clinical Research |
0 |
0.34 |
| Proteases |
0 |
0.34 |
| Food and Drug Administration (FDA) |
0 |
0.22 |
| Severe Acute Respiratory Syndrome |
0 |
0.22 |
| Acute Respiratory Distress Syndrome |
0 |
0.18 |
| Calcaneal |
0 |
0.11 |
| Hospital |
0 |
0.11 |
| Investment |
0 |
0.11 |
| Pandemic |
0 |
0.11 |
| UK Site Content |
0 |
0.11 |
| Vaccines |
0 |
0.09 |